Avance, Basel GmbH

Avance is a Swiss company specialized in valuation in life sciences. The company serves pharma, biotech and investors with valuation tools, publications and services related to valuation and financial aspects of licensing, fundraising, investing and portfolio managment.

 Avance, Basel GmbH
 

List of reports from Avance, Basel GmbH

Biotech Success Rates - Period 2002 - 2009
4/23/2009 | published by: Avance, Basel GmbH
... publicly traded biotech companies with more than 1,500 drugs in development fort he period 2002 - 2009. The success rates are discussed per disease group and put into context to existing data on drug development ...  |  more...
Search inside this report
$1,285.00
 

Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!